Japanese headquartered Sysmex has signed a deal to acquire Oxford Gene Technology IP Limited. This is evidence that the UK continues to be an ideal base for creating world leading innovative life science businesses capable of attracting foreign investment via acquisitions and directly into facilities.
NEW YORK (GenomeWeb) – Sysmex, a Japanese in vitro diagnostics company, has signed a deal to acquire all the shares of Oxford Gene Technology....OGT will become a wholly owned subsidiary of Sysmex....The deal is likely to close by mid-June. Once Sysmex acquires OGT, the British maker of molecular analysis tools will remain intact as a company, answering directly to Sysmex's management in Kobe. "There will be no change in corporate structure, and the various companies within the OGT group will remain," Hall said. OGT was founded in 1995 by Edwin Southern, a University of Oxford molecular biologist and microarray innovator. The company expanded under the stewardship of Mike Evans, who joined as CEO in 2005, and OGT acquired Sense Proteomic in 2009, and Cytocell in 2014, while developing its array and next-generation sequencing offerings. It currently employs around 100 people.